German Health Economic Cost Evaluation on Oral Ganciclovir in Treating Cytomegalovirus Retinitis
- 1 November 1996
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 10 (5) , 522-530
- https://doi.org/10.2165/00019053-199610050-00009
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Randomized, Controlled Study of the Safety and Efficacy of Intravenous Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDSJAIDS Journal of Acquired Immune Deficiency Syndromes, 1998
- Oral Ganciclovir as Maintenance Treatment for Cytomegalovirus Retinitis in Patients with AIDSNew England Journal of Medicine, 1995
- Central venous catheter infections in AIDS patients receiving treatment for cytomegalovirus disease.1994
- Cytomegalovirus Retinitis: Diagnosis and TreatmentInternational Journal of STD & AIDS, 1993
- Low infection rate and long durability of nontunneled silastic catheters. A safe and cost-effective alternative for long-term venous access.1993
- Treatment and Prophylaxis of Cytomegalovirus DiseasePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1992
- Survival of patients with AIDS and cytomegalovirus disease treated with ganciclovir or foscarnetAIDS, 1991
- Central venous catheter related sepsis: a clinical reviewResuscitation, 1990
- GanciclovirDrugs, 1990
- Infections associated with hickman catheters in patients with acquired immunodeficiency syndromeThe American Journal of Medicine, 1989